THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

VOLORIDGE INVESTMENT MANAGEMENT, LLC's Holding History (CIK: 0001556921)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023

Shares 15,936 Value ($000) $173 Avg Close $10.57 Range $9.25 - $11.52

Q4 2022

Shares 45,813 Value ($000) $514 Avg Close $10.51 Range $9.56 - $11.83

Q2 2022

Shares 252,845 Value ($000) $2,291 Avg Close $9.21 Range $8.15 - $10.52

Q1 2022

Shares 335,106 Value ($000) $3,204 Avg Close $9.80 Range $7.71 - $13.17

Q4 2021

Shares 174,070 Value ($000) $1,923 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 220,894 Value ($000) $1,635 Avg Close $11.19 Range $6.10 - $15.01

Q3 2020

Shares 34,899 Value ($000) $516 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 61,091 Value ($000) $1,282 Avg Close $25.69 Range $20.17 - $31.35

Q4 2019

Shares 29,102 Value ($000) $753 Avg Close $19.43 Range $15.72 - $26.47

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2023	15,936	$173	$10.57	$9.25 - $11.52
Q4 2022	45,813	$514	$10.51	$9.56 - $11.83
Q2 2022	252,845	$2,291	$9.21	$8.15 - $10.52
Q1 2022	335,106	$3,204	$9.80	$7.71 - $13.17
Q4 2021	174,070	$1,923	$8.72	$7.30 - $11.24
Q3 2021	220,894	$1,635	$11.19	$6.10 - $15.01
Q3 2020	34,899	$516	$18.73	$14.62 - $22.82
Q2 2020	61,091	$1,282	$25.69	$20.17 - $31.35
Q4 2019	29,102	$753	$19.43	$15.72 - $26.47